| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0002-9343(02)01055-0 |
| P698 | PubMed publication ID | 12113867 |
| P2093 | author name string | Allan Ronald | |
| P2860 | cites work | A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group | Q28373068 |
| Urinary tract infections in children younger than 5 years of age: epidemiology, diagnosis, treatment, outcomes and prevention | Q30307269 | ||
| Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women | Q33853747 | ||
| Binding of pili from uropathogenic Escherichia coli to membranes secreted by human colonocytes and enterocytes | Q34002581 | ||
| Pathogenesis of Proteus mirabilis urinary tract infection | Q34094890 | ||
| Host pathogenesis in urinary tract infections | Q34214073 | ||
| Urinary tract infections in adults with diabetes. | Q34214103 | ||
| Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates | Q34750532 | ||
| Treatment of uncomplicated urinary tract infection in non-pregnant women | Q36809074 | ||
| Secular trends in rates and etiology of nosocomial urinary tract infections at a university hospital. | Q38512350 | ||
| Management of urinary tract infections in adults | Q40865662 | ||
| Diagnosis and treatment of uncomplicated urinary tract infection | Q41649429 | ||
| Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial | Q41726797 | ||
| The emergence and mechanisms of trimethoprim resistance in Escherichia coli isolated from outpatients in Finland | Q43676437 | ||
| Prevention of recurrent urinary-tract infections in women | Q44396735 | ||
| Management of urinary tract infections in the elderly | Q44821423 | ||
| Unique epidemiology of nosocomial urinary tract infection in children | Q45134307 | ||
| Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. | Q54067789 | ||
| P-fimbriation and haemolysin production are the most important virulence factors in diabetic patients with Escherichia coli bacteraemia: a multivariate statistical analysis of seven bacterial virulence factors. | Q54168471 | ||
| Epidemic Outbreaks of Acute Pyelonephritis Caused by Nosocomial Spread of P Fimbriated Escherichia coli in Children | Q54466549 | ||
| Urinary tract infection in adults: research priorities and strategies | Q57991131 | ||
| The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections | Q67507006 | ||
| Group B streptococcus bacteremia in nonpregnant adults | Q73016131 | ||
| Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group | Q73321118 | ||
| Microbiologic survey of long-term care facilities | Q73458535 | ||
| Urinary tract infection in diabetic patients | Q73613323 | ||
| Low virulence of Escherichia coli strains causing urinary tract infection in renal disease patients | Q73841836 | ||
| Risk factors for second urinary tract infection among college women | Q74034271 | ||
| Practice guidelines for urinary tract infection in the era of managed care | Q77965141 | ||
| P921 | main subject | urinary tract infection | Q221668 |
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 14S-19S | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | The etiology of urinary tract infection: traditional and emerging pathogens | |
| P478 | volume | 113 Suppl 1A |
| Q37451874 | (CGG)4-based PCR as a novel tool for discrimination of uropathogenic Escherichia coli strains: comparison with enterobacterial repetitive intergenic consensus-PCR. |
| Q34283239 | A comprehensive review of urologic complications in patients with diabetes |
| Q57179220 | A review on the development of urease inhibitors as antimicrobial agents against pathogenic bacteria |
| Q33809809 | A survey of pathogens associated with Cyperus esculentus L (tiger nuts) tubers sold in a Ghanaian city |
| Q35647771 | Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice. |
| Q38543398 | Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis |
| Q34569154 | Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumoniae |
| Q42845236 | Antimicrobial and clinical efficacy of nitrofurantoin in the treatment of acute lower urinary tract infections in adults |
| Q46912782 | Antimicrobial resistance determinants in Staphylococcus spp. recovered from birds of prey in Portugal |
| Q38296425 | Antimicrobial resistance patterns in cases of obstructive pyelonephritis secondary to stones |
| Q34220539 | Antimicrobial susceptibility of community-acquired uropathogens in general practice |
| Q34476132 | Antimicrobial susceptibility patterns of enterobacteriaceae isolated from HIV-infected patients in Kinshasa |
| Q35745979 | Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in jimma university specialized hospital, southwest ethiopia |
| Q55339999 | Bacteriological profile and antimicrobial susceptibility patterns of urine culture isolates from patients in Ndjamena, Chad. |
| Q35171959 | Bacteriuria among adult non-pregnant women attending Mulago hospital assessment centre in Uganda |
| Q36196021 | Carriage of Class 1 and 2 Integrons in Quinolone, Extended-Spectrum-β-Lactamase-Producing and Multi Drug Resistant E.coli and K.pneumoniae: High Burden of Antibiotic Resistance. |
| Q27331629 | Catch-bond mechanism of the bacterial adhesin FimH. |
| Q34420965 | Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients |
| Q58796488 | Characteristics of Dogs with Biofilm-Forming Escherichia Coli Urinary Tract Infections |
| Q47392637 | Characterization of biofilm formation by Enterococcus faecalis isolates derived from urinary tract infections in China |
| Q34119229 | Characterization of the structure and biological functions of a capsular polysaccharide produced by Staphylococcus saprophyticus |
| Q36181807 | Chronic bacterial prostatitis: an evolving clinical enigma |
| Q83094724 | Clinical significance of bacteriuria with low colony counts of Enterococcus species |
| Q64997044 | Clinical usefulness of iQ200/iChem Velocity workstation for screening of urine culture. |
| Q34470294 | Colonization, competition, and dispersal of pathogens in fluid flow networks |
| Q92354647 | Community acquired urinary tract infections among adults in Accra, Ghana |
| Q49960296 | Complete Genome Sequences of Enterobacter cancerogenus CR-Eb1 and Enterococcus sp. Strain CR-Ec1, Isolated from the Larval Gut of the Greater Wax Moth, Galleria mellonella |
| Q28541905 | Comprehensive logic based analyses of Toll-like receptor 4 signal transduction pathway |
| Q37191353 | Conditioning of uropathogenic Escherichia coli for enhanced colonization of host |
| Q35805388 | Developing animal models for polymicrobial diseases |
| Q35403048 | Diagnosing inflammation and infection in the urinary system via proteomics. |
| Q34170842 | Diagnosis and management of urinary infections in older people. |
| Q36124083 | Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli |
| Q44939134 | Doctor characteristics and prescribing antibiotics for urinary tract infections: the experience of an Asian country |
| Q36951570 | Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. |
| Q84875070 | Dynamic magnetic resonance imaging in acute pyelonephritis |
| Q28475353 | Early Severe Inflammatory Responses to Uropathogenic E. coli Predispose to Chronic and Recurrent Urinary Tract Infection |
| Q85368554 | Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis |
| Q48439311 | Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study |
| Q41553610 | Effects of azithromycin on Pseudomonas aeruginosa isolates from catheter-associated urinary tract infection |
| Q50020710 | Efficacy and Safety of Finafloxacin versus Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections: An Explorative Randomized Phase II Clinical Study |
| Q97418485 | Efficacy of Acacia nilotica aqueous extract in treating biofilm-forming and multidrug resistant uropathogens isolated from patients with UTI syndrome |
| Q36018630 | Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high |
| Q34177412 | Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. |
| Q38090339 | Enterotoxigenic potential of coagulase-negative staphylococci |
| Q35171757 | Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs |
| Q90381422 | Evaluation of Immunocompetent Urinary Tract Infected Balb/C Mouse Model For the Study of Antibiotic Resistance Development Using Escherichia Coli CFT073 Infection |
| Q90494489 | Fast and Accurate Bacterial Species Identification in Urine Specimens Using LC-MS/MS Mass Spectrometry and Machine Learning |
| Q54442022 | Flushing bacteria out of the bladder. |
| Q34552718 | Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). |
| Q30424697 | From in vitro to in vivo Models of Bacterial Biofilm-Related Infections. |
| Q42720826 | Genome Sequence of Klebsiella pneumoniae Urinary Tract Isolate Top52. |
| Q36163174 | Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection |
| Q37191735 | Genomic islands of uropathogenic Escherichia coli contribute to virulence |
| Q28829569 | Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract |
| Q42367000 | Group B Streptococcus: An Unusual Cause for Urinary Tract Infection |
| Q40277756 | Highlights for management of a child with a urinary tract infection |
| Q34951284 | Highly resistant metabolically deficient dwarf mutant of Escherichia coli is the cause of a chronic urinary tract infection |
| Q93162262 | Host Cathelicidin Exacerbates Group B Streptococcus Urinary Tract Infection |
| Q36910650 | Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection |
| Q34440629 | How to make it in the urinary tract: a tutorial by Escherichia coli |
| Q35025542 | Human bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coli. |
| Q57071578 | Identification of in the urine of an individual with spinal cord injury and augmentation cystoplasty using 16S sequencing: copathogen or innocent bystander? |
| Q35646813 | Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice |
| Q91313698 | Improvement of Aglycone π-Stacking Yields Nanomolar to Sub-nanomolar FimH Antagonists |
| Q55384052 | In Vitro Synergism of Silver Nanoparticles with Antibiotics as an Alternative Treatment in Multiresistant Uropathogens. |
| Q50077307 | In Vivo Bioluminescent Monitoring of Therapeutic Efficacy and Pharmacodynamic Target Assessment of Antofloxacin against Escherichia coli in a Neutropenic Murine Thigh Infection Model |
| Q35776444 | In vitro Antibacterial Activity of Ocimum suave Essential Oils against Uropathogens Isolated from Patients in Selected Hospitals in Bushenyi District, Uganda |
| Q34230852 | In vitro evaluation of a new treatment for urinary tract infections caused by nitrate-reducing bacteria |
| Q34523193 | Increasing ciprofloxacin resistance of isolates from infected urines of a cross-section of patients in Karachi |
| Q42277205 | Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates. |
| Q33290835 | Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli |
| Q36773074 | Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study. |
| Q54414284 | Kinetic properties of carbohydrate-lectin interactions: FimH antagonists. |
| Q38192498 | Mechanisms of synergy in polymicrobial infections |
| Q37172122 | Microbial Content of "bowl Water" Used for Communal Handwashing in Preschools within Accra Metropolis, Ghana |
| Q35171765 | Microbial virulence determinants and the pathogenesis of urinary tract infection |
| Q33769013 | Molecular cloning and characterization of three beta-defensins from canine testes |
| Q37023346 | Molecular imaging of nuclear factor-κB in bladder as a primary regulator of inflammatory response |
| Q93054603 | Murine SIGNR1 (CD209b) Contributes to the Clearance of Uropathogenic Escherichia coli During Urinary Tract Infections |
| Q26863396 | NGAL-Siderocalin in kidney disease |
| Q33896695 | PI3K/Akt pathway restricts epithelial adhesion of Dr + Escherichia coli by down-regulating the expression of decay accelerating factor |
| Q40091442 | Partial Purification and Characterization of a Bacteriocin DT24 Produced by Probiotic Vaginal Lactobacillus brevis DT24 and Determination of its Anti-Uropathogenic Escherichia coli Potential. |
| Q34985006 | Pathogenesis of infections due to coagulase-negative staphylococci |
| Q33601794 | Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections |
| Q92339839 | Prevalence and molecular characteristics of sequence type 131 clone among clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia |
| Q36457170 | Prevalence of Urinary Tract Infection and Antimicrobial Susceptibility among Diabetic Patients with Controlled and Uncontrolled Glycemia in Kuwait |
| Q35586984 | Prevalence of bacterial febrile illnesses in children in Kilosa district, Tanzania |
| Q37300937 | Prevention of recurrent urinary tract infections by intravesical administration of heparin: a pilot study |
| Q34458308 | Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patients |
| Q57262003 | ProteoStorm: An Ultrafast Metaproteomics Database Search Framework |
| Q44997318 | Rapid detection of urinary tract infections caused by Proteus spp. using PNA-FISH. |
| Q37109572 | Recurrent Urinary Tract Infections Management in Women: A review |
| Q35046832 | Revisiting the host as a growth medium |
| Q37035991 | Role of Klebsiella pneumoniae type 1 and type 3 fimbriae in colonizing silicone tubes implanted into the bladders of mice as a model of catheter-associated urinary tract infections |
| Q35230814 | Role of duration of catheterization and length of hospital stay on the rate of catheter-related hospital-acquired urinary tract infections |
| Q26747710 | Role of the microbiome in non-gastrointestinal cancers |
| Q33614157 | Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation |
| Q33415985 | Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli |
| Q35860382 | SIGIRR participates in negative regulation of LPS response and tolerance in human bladder epithelial cells |
| Q36572761 | Sexual intercourse and risk of symptomatic urinary tract infection in post-menopausal women |
| Q37336037 | Significance of the D-serine-deaminase and D-serine metabolism of Staphylococcus saprophyticus for virulence |
| Q36053469 | Similar Neutrophil-Driven Inflammatory and Antibacterial Responses in Elderly Patients with Symptomatic and Asymptomatic Bacteriuria |
| Q37613036 | Single clinical isolates from acute uncomplicated urinary tract infections are representative of dominant in situ populations |
| Q36902491 | Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies. |
| Q85066834 | Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance |
| Q37198151 | The clinical effectiveness of intravesical sodium hyaluronate (cystistat®) in patients with interstitial cystitis/painful bladder syndrome and recurrent urinary tract infections |
| Q35544680 | The microbiome of the urinary tract--a role beyond infection |
| Q37050386 | The nature of immune responses to urinary tract infections |
| Q52599567 | The price of flexibility - a case study on septanoses as pyranose mimetics. |
| Q41765999 | The transcriptional antiterminator RfaH represses biofilm formation in Escherichia coli. |
| Q36458378 | The treatment of urinary tract infections and use of ciprofloxacin extended release |
| Q42793508 | Type 3 fimbriae and biofilm formation are regulated by the transcriptional regulators MrkHI in Klebsiella pneumoniae |
| Q40347769 | Urinary tract infections in children |
| Q64449409 | Urinary tract infections in women |
| Q37084979 | Urinary tract infections: current and emerging management strategies |
| Q27022487 | Urinary tract infections: epidemiology, mechanisms of infection and treatment options |
| Q47245755 | Urine trouble: should we think differently about UTI? |
| Q34111754 | Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization |
| Q37029864 | Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway. |
| Q41935408 | Urosepsis with Actinobaculum schaalii and Aerococcus urinae |
| Q47100141 | Urothelial cells may indicate underlying bacteriuria in pregnancy at term: a comparative study |
| Q64069992 | Use of ceragenins as a potential treatment for urinary tract infections |
| Q35158122 | Value of an aggregate index in describing the impact of trends in antimicrobial resistance for Escherichia coli. |
| Q33698236 | Voided midstream urine culture and acute cystitis in premenopausal women |
| Q34597729 | Within-population distribution of trimethoprim resistance in Escherichia coli before and after a community-wide intervention on trimethoprim use |
| Q83577912 | [Urogenic spondylodiscitis] |
| Q90292866 | yqhG Contributes to Oxidative Stress Resistance and Virulence of Uropathogenic Escherichia coli and Identification of Other Genes Altering Expression of Type 1 Fimbriae |
Search more.